A hyperinsulinaemic, sequentially eu- and hypoglycaemic clamp test to characterize autonomous insulin secretion in patients with insulinoma

European Journal of Clinical Investigation

Volumn 27, Issue 2, 1997, Pages 109-115

  Nauck, M A ^a,b   Baum, F ^a   Seidensticker, F ^a,b   Roder M ^c   Dinesen, B ^c   Creutzfeldt, W ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c STENO DIABETES CENTER   (Denmark)

Author keywords

autonomous insulin secretion; C peptide; hypoglycaemia; insulinoma; proinsulin

Indexed keywords

C PEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; INSULINOMA; PRIORITY JOURNAL;

EID: 0031054557     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.630621.x     Document Type: Article

References (28)

1. Nauck M, Creutzfeldt W. Insulin-producing tumors and the insulin-oma syndrome. In: Dayal Y, ed. Endocrine Pathology of the Gut and Pancreas. Boca Raton: CRC Press, 1991; 195-225.
2. Creutzfeldt W, Arnold R, Creutzfeldt C, Deuticke U, Frerichs H, Track NS. Biochemical and morphological investigation in 30 human insulinomas. Correlation between tumour content of insulin and proinsulin-like components and the histological and ultrastructural appearance. Diabetologia 1973;9:217-31.
3. Service FJ, Dale AJD, Elveback LR, Jiang N-S. Insulinoma. Clinical and diagnostic features of 60 consecutive cases. Mayo Clinic Proc 1976;51:417-29.
4. Marks V, Samols E. Insulinoma: natural history and diagnosis. Clin Gastroenterol 1974;3:559-73.
5. Yki-Järvinen H, Pelkonen R, Koivisto VA. Failure to suppress C-peptide secretion by euglycemic hyperinsulinaemia: A new diagnostic test for insulinoma? Clin Endocrinol 1985;23:461-6.
6. Reynolds JH, Kaminsky NI, Schade DS, Eaton RP. Use of a computerized glucose clamp technique to diagnose an insulinoma. Ann Intern Med 1984;101:648-9.
7. Cohen P, Barzilai N, Bar-Ilan R, Yassin K, Karnieli E. Lack of suppression of insulin secretion by hyperinsulinaemia in a patient with an insulinoma. J Clin Endocrinol Metab 1986;63: 1411-13.
8. Gin H, Brottier E, Dupuy B, Guillaume D, Ponzo J, Aubertin J. Use of a glucose clamp technique for confirmation of insulinoma autonomous hyperinsulinism. Arch Intern Med 1987;147: 985-7.
9. Koivisto VA, Yki-Järvinen H, Hartling SG, Pelkonen R. The effect of exogenous hyperinsulinemia on proinsulin secretion in normal man, obese subjects, and patients with insulinoma. J Clin Endocrinol Metab 1986;63:1117-20.
10. Service FJ, Horwitz DL, Rubenstein AH et al. C-peptide suppression test for insulinoma. J Clin Med Lab 1977;90:180-6.
11. Turner RC, Harris E. Diagnosis of insulinomas by suppression tests. Lancet 1974;2:188-90.
12. Turner RC, Heding LG. Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas. Diabetologia 1977; 13:571-7.
13. Service FJ, O'Brien PC, Kao PC, Young WF Jr. C-peptide suppression test: Effects of gender, age, and body-mass-index; implications for the diagnosis of insulinoma. J Clin Endocrinol Metab 1992; 74:204-10.
14. Hütter R, Irsigler K, Vèsely M, Orgis E. Hypoglykämische und hyperinsulinämische Clamp-Technik zur Ermittlung des Sekretionsverhaltens von Insulinomen. Dtsch Med Wschr 1988;113: 1146-8.
15. Merimee TJ, Tyson JE. Stabilization of plasma glucose during fasting. Normal variation in two separate studies. N Engl J Med 1974;291:1275-8.
16. Merimee TJ, Tyson JE. Hypoglycemia in man. Pathologic and physiologic variants. Diabetes 1977;26:161-5.
17. Nauck M, Stöckmann F, Creutzfeldt W. Evaluation of a euglycemic clamp procedure as a diagnostic test in insulinoma patients. Eur J Clin Invest 1990;20:15-28.
18. Nankervis A, Proietto J, Aitken P, Alford F. Hyperinsulinaemia and insulin insensitivity: studies in subjects with insulinoma. Diabetologia 1985;28:427-31.
19. McGee GS, Kulaylat MM, Abumrad NN. Defective glucose utilization in patients with functioning β-cell tumors persists after tumor excision. Ann Surg 1987;206:449-57.
20. Nauck M, Baum F, Creutzfeldt W. Hyperinsulinämischer euglykämischer und hypoglykämischer 'Clamp'-test zum Nachweis einer fehlenden Supprimierbarkeit der Insulinsekretion bei Insulinompatienten (abstract). Diabetes Stoffw 1992;1:107.
21. Turner RC, Oakley NW, Nabarro JDN. Control of basal insulin secretion, with special reference to the diagnosis of insulinomas. Br Med J 1971;2:132-5.
22. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E 214-23.
23. Kjems LL, Røder ME, Dinesen B, Hartling SG, Jorgensen PN, Binder C. Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies. Clin Chem 1993;39:2146-150.
24. Yasunami Y, Funakoshi A, Ono J, Miyazaki K, Jimi A, Konomi K. In vitro study of cultured insulinoma cells: evidence for abnormal sensitivity to glucose. J Clin Endocrinol Metab 1987;65:110-15.
25. Chou H-F, Ipp E, Bowsher RR, Berman N, Ezrin C, Griffiths S. Sustained pulsatile insulin secretion from adenomatous human β-cells. Diabetes 1991;40:1453-8.
26. Ipp E, Sinai Y, Forster B et al. A glucose reduction challenge in the differential diagnosis of fasting hypoglycemia: a two-center study. J Clin Endocrinol Metab. 1990;70:711-17.
27. Mitrakou A, Fanelli C, Veneman T et al. Reversibility of unawareness of hypoglycemia in patients with insulinomas. N Engl J Med 1993;329:834-9.
28. Baum F, Nauck MA, Hüfner M, Niedmann PD, Creutzfeldt W. Reduced counterregulatory response of glucagon, adrenalin, and cortisol, but not growth hormone, during hypoglycaemia in insulin-oma patients (abstract). Diabetologia 1992;35:A186.